Impax Asset Management Group Portfolio holdings
AUM
$17.4B
1-Year Return
13.12%
This Quarter Return
-5.54%
1 Year Return
+13.12%
3 Year Return
+65.42%
5 Year Return
+126.12%
10 Year Return
–
AUM
$22.4B
AUM Growth
-$2.5B
(-10%)
Cap. Flow
-$1.13B
Cap. Flow
% of AUM
-5.07%
Top 10 Holdings %
Top 10 Hldgs %
28.77%
Holding
399
New
11
Increased
74
Reduced
285
Closed
4
Top Buys
| 1 |
Carrier Global
CARR
|
$122M |
| 2 |
Becton Dickinson
BDX
|
$97.6M |
| 3 |
Aptiv
APTV
|
$64.7M |
| 4 |
Mettler-Toledo International
MTD
|
$46.7M |
| 5 |
Steris
STE
|
$40.4M |
Top Sells
| 1 |
Equinix
EQIX
|
$272M |
| 2 |
WRK
WestRock Company
WRK
|
$132M |
| 3 |
Deere & Co
DE
|
$112M |
| 4 |
Boston Scientific
BSX
|
$93.5M |
| 5 |
Vertiv
VRT
|
$77.6M |
Sector Composition
| 1 | Industrials | 30.88% |
| 2 | Technology | 23.49% |
| 3 | Healthcare | 15% |
| 4 | Financials | 6.72% |
| 5 | Materials | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAMI
126
Acadian Asset Management Inc.
AAMI
$1.53B
| $18.4M | 0.08% |
948,818
+75,000
| +9% | +$1.45M |
|
|
WRK
127
DELISTED
WestRock Company
WRK
| $17M | 0.08% |
475,122
-3,675,523
| -89% | -$132M |
|
128
Bristol-Myers Squibb
BMY
$96B
| $16.1M | 0.07% |
278,066
-7,511
| -3% | -$436K |
|
129
Onto Innovation
ONTO
$5.1B
| $15.9M | 0.07% |
125,057
-12,500
| -9% | -$1.59M |
|
130
Eli Lilly
LLY
$652B
| $15.4M | 0.07% |
28,708
-2,181
| -7% | -$1.17M |
|
131
Neurocrine Biosciences
NBIX
$14.3B
| $15.2M | 0.07% |
135,000
-65,000
| -33% | -$7.31M |
|
132
Huron Consulting
HURN
$2.44B
| $15M | 0.07% |
144,000
-50,000
| -26% | -$5.21M |
|
133
Edison International
EIX
$21B
| $14.9M | 0.07% |
234,727
-20,181
| -8% | -$1.28M |
|
134
Healthcare Realty
HR
$6.35B
| $14.8M | 0.07% |
967,722
+61,370
| +7% | +$937K |
|
135
Gates Industrial
GTES
$6.68B
| $14.3M | 0.06% |
1,227,713
| – | – |
|
136
Coca-Cola
KO
$292B
| $14.1M | 0.06% |
251,438
-13,370
| -5% | -$748K |
|
137
Workiva
WK
$4.48B
| $13.8M | 0.06% |
136,086
| – | – |
|
138
Ciena
CIEN
$16.5B
| $13.4M | 0.06% |
283,064
+30,000
| +12% | +$1.42M |
|
139
Johnson & Johnson
JNJ
$430B
| $12.6M | 0.06% |
80,695
-16,730
| -17% | -$2.61M |
|
140
Starbucks
SBUX
$97.1B
| $12.5M | 0.06% |
136,547
-5,406
| -4% | -$493K |
|
141
Gilead Sciences
GILD
$143B
| $12.2M | 0.05% |
163,417
+53,704
| +49% | +$4.02M |
|
|
WBA
142
DELISTED
Walgreens Boots Alliance
WBA
| $12.2M | 0.05% |
548,132
+332,967
| +155% | +$7.41M |
|
143
General Mills
GIS
$27B
| $12.2M | 0.05% |
190,500
+900
| +0.5% | +$57.6K |
|
144
Citigroup
C
$176B
| $12.1M | 0.05% |
294,740
+105,822
| +56% | +$4.35M |
|
145
Elevance Health
ELV
$70.6B
| $12.1M | 0.05% |
27,687
-18
| -0.1% | -$7.84K |
|
|
AXNX
146
DELISTED
Axonics, Inc. Common Stock
AXNX
| $12M | 0.05% |
214,525
| – | – |
|
147
Celanese
CE
$5.34B
| $11.9M | 0.05% |
94,837
-23,112
| -20% | -$2.9M |
|
148
lululemon athletica
LULU
$19.9B
| $11.9M | 0.05% |
30,794
-4,261
| -12% | -$1.64M |
|
149
Cardinal Health
CAH
$35.7B
| $11.8M | 0.05% |
135,777
-9,967
| -7% | -$865K |
|
150
QuinStreet
QNST
$920M
| $11.8M | 0.05% |
1,310,395
+180,477
| +16% | +$1.62M |
|